| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.4 | 0.01 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |